Index S&P 500
P/E 18.93
EPS (ttm) 28.52
Insider Own 0.41%
Shs Outstand 233.07M
Perf Week -1.99%
Market Cap 125.19B
Forward P/E 12.96
EPS next Y 41.65
Insider Trans -5.50%
Shs Float 230.92M
Perf Month -0.46%
Income 6.69B
PEG 1.57
EPS next Q 9.70
Inst Own 91.67%
Short Float 0.77%
Perf Quarter 1.02%
Sales 171.72B
P/S 0.73
EPS this Y 12.43%
Inst Trans 0.08%
Short Ratio 1.87
Perf Half Y 4.89%
Book/sh 181.93
P/B 2.97
EPS next Y 11.79%
ROA 6.02%
Short Interest 1.78M
Perf Year 21.09%
Cash/sh -
P/C -
EPS next 5Y 12.05%
ROE 16.65%
52W Range 431.38 - 567.26
Perf YTD 14.48%
Dividend Est. 6.32 (1.17%)
P/FCF 152.67
EPS past 5Y 12.18%
ROI 10.02%
52W High -4.83%
Beta 0.83
Dividend TTM 6.37 (1.18%)
Quick Ratio -
Sales past 5Y 13.24%
Gross Margin -
52W Low 25.15%
ATR (14) 9.32
Dividend Ex-Date Sep 10, 2024
Current Ratio 1.49
EPS Y/Y TTM 6.53%
Oper. Margin 5.48%
RSI (14) 46.96
Volatility 1.51% 1.71%
Employees 104900
Debt/Eq 0.66
Sales Y/Y TTM 3.62%
Profit Margin 3.90%
Recom 1.61
Target Price 607.61
Option/Short Yes / Yes
LT Debt/Eq 0.58
EPS Q/Q 26.46%
Payout 23.47%
Rel Volume 1.76
Prev Close 538.00
Sales Surprise 0.55%
EPS Surprise 1.22%
Sales Q/Q -0.06%
Earnings Jul 17 BMO
Avg Volume 952.17K
Price 539.86
SMA20 -1.31%
SMA50 0.78%
SMA200 4.69%
Trades
Volume 1,677,101
Change 0.35%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-18-24 Downgrade
BofA Securities
Buy → Neutral
$646 → $530
Jun-24-24 Initiated
Morgan Stanley
Overweight
$643
May-30-24 Initiated
Robert W. Baird
Outperform
$649
Mar-06-24 Initiated
Barclays
Overweight
$584
Jul-12-23 Downgrade
Wolfe Research
Outperform → Peer Perform
Apr-27-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$500 → $571
Apr-21-23 Initiated
Cantor Fitzgerald
Overweight
$547
Mar-28-23 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$523 → $572
Sep-09-22 Upgrade
BofA Securities
Neutral → Buy
$535 → $575
Aug-22-22 Upgrade
SVB Leerink
Mkt Perform → Outperform
$490 → $580
Sep-13-24 05:08AM
Sep-05-24 12:58PM
07:59AM
Aug-29-24 03:01AM
Aug-25-24 04:22PM
03:09PM
Loading…
Aug-22-24 03:09PM
Aug-20-24 04:40PM
Aug-19-24 08:39AM
Aug-16-24 11:30AM
Aug-13-24 07:08PM
Aug-12-24 10:00AM
Aug-06-24 11:30PM
Aug-02-24 07:43AM
Jul-31-24 05:00PM
Jul-29-24 03:29PM
10:40PM
Loading…
Jul-26-24 10:40PM
Jul-25-24 07:00AM
(The Wall Street Journal)
Jul-23-24 12:23AM
Jul-19-24 12:33PM
(The Wall Street Journal)
Jul-18-24 02:58AM
(Thomson Reuters StreetEvents)
01:01AM
Jul-17-24 01:33PM
12:00PM
10:52AM
10:42AM
10:16AM
(The Wall Street Journal)
10:02AM
(The Wall Street Journal)
09:30AM
07:10AM
06:18AM
06:17AM
Loading…
06:17AM
(The Wall Street Journal)
06:06AM
(Associated Press Finance)
06:00AM
Jul-16-24 09:40AM
Jul-12-24 02:40PM
09:15AM
Jul-10-24 10:00AM
Jul-08-24 01:00PM
12:22PM
Jul-04-24 05:30AM
(The Wall Street Journal)
Jul-03-24 07:50AM
Jun-30-24 11:42AM
Jun-28-24 09:40AM
Jun-27-24 03:56PM
(Investor's Business Daily)
Jun-26-24 04:05PM
Jun-23-24 10:25AM
Jun-20-24 12:22PM
Jun-19-24 03:25PM
12:02PM
Jun-14-24 11:00AM
Jun-13-24 09:16PM
(The Wall Street Journal)
12:56PM
09:45AM
Jun-12-24 12:31PM
09:40AM
Jun-10-24 07:01AM
Jun-07-24 10:16PM
Jun-03-24 11:22AM
May-30-24 04:05PM
May-28-24 09:45AM
May-27-24 09:40AM
May-24-24 05:09PM
May-22-24 05:17PM
May-21-24 12:39PM
May-20-24 04:05PM
May-10-24 09:45AM
May-09-24 09:40AM
09:15AM
May-01-24 09:30AM
Apr-29-24 05:22PM
Apr-26-24 09:50AM
02:25AM
Apr-25-24 05:16PM
12:00PM
Apr-24-24 09:45AM
Apr-23-24 09:40AM
Apr-22-24 07:00AM
(The Wall Street Journal)
Apr-19-24 09:32AM
03:02AM
01:01AM
Apr-18-24 11:49PM
(Thomson Reuters StreetEvents)
04:27PM
03:53PM
12:15PM
11:58AM
11:18AM
10:53AM
10:45AM
(The Wall Street Journal)
09:41AM
09:30AM
08:15AM
07:10AM
06:17AM
06:09AM
(Associated Press Finance)
06:03AM
06:00AM
Apr-17-24 10:33AM
Apr-16-24 06:25PM
(The Wall Street Journal)
12:13PM
Apr-15-24 04:17PM
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
PERU RAMIRO G Director Aug 05 '24 Sale 531.52 753 400,235 8,744 Aug 06 05:23 PM RAMIRO G PERU Director Aug 05 '24 Proposed Sale 531.52 753 400,235 Aug 05 04:14 PM BOUDREAUX GAIL President and CEO Jul 22 '24 Sale 500.98 34,000 17,033,395 126,709 Jul 23 05:02 PM Dixon Robert L JR Director Jul 19 '24 Sale 506.76 305 154,562 9,721 Jul 22 04:30 PM Norwood Felicia F EVP & President,Gov Health Ben Apr 23 '24 Option Exercise 238.27 5,473 1,304,052 45,571 Apr 25 05:05 PM Norwood Felicia F EVP & President,Gov Health Ben Apr 24 '24 Option Exercise 238.27 2,043 486,786 33,503 Apr 25 05:05 PM Norwood Felicia F EVP & President,Gov Health Ben Apr 23 '24 Sale 533.74 14,111 7,531,565 31,460 Apr 25 05:05 PM Norwood Felicia F EVP & President,Gov Health Ben Apr 24 '24 Sale 532.44 6,199 3,300,590 27,304 Apr 25 05:05 PM Kendrick Charles Morgan JR EVP & President, Commercial Mar 08 '24 Sale 500.46 2,432 1,217,119 15,840 Mar 12 04:26 PM Penczek Ronald W CAO & Controller Mar 06 '24 Sale 504.58 916 462,195 1,764 Mar 08 04:16 PM Haytaian Peter D EVP & Pres Carelon & CarelonRx Mar 04 '24 Option Exercise 166.97 15,000 2,504,550 39,982 Mar 05 04:24 PM Haytaian Peter D EVP & Pres Carelon & CarelonRx Mar 04 '24 Sale 500.18 21,095 10,551,297 18,887 Mar 05 04:24 PM PERU RAMIRO G Director Feb 07 '24 Sale 500.00 753 376,500 9,109 Feb 09 04:22 PM Todt Blair Williams EVP, CLO & CAO Dec 14 '23 Option Exercise 311.48 5,492 1,710,648 18,004 Dec 15 04:28 PM Todt Blair Williams EVP, CLO & CAO Dec 14 '23 Sale 484.02 5,492 2,658,238 12,512 Dec 15 04:28 PM Penczek Ronald W CAO & Controller Nov 30 '23 Sale 475.17 1,055 501,304 1,787 Dec 01 04:21 PM Penczek Ronald W CAO & Controller Oct 24 '23 Sale 454.35 64 29,078 2,842 Oct 26 04:15 PM
Index RUT
P/E 5.98
EPS (ttm) 6.94
Insider Own 1.66%
Shs Outstand 115.75M
Perf Week 6.05%
Market Cap 4.75B
Forward P/E 4.72
EPS next Y 8.81
Insider Trans -4.84%
Shs Float 112.52M
Perf Month -6.49%
Income 810.95M
PEG 0.75
EPS next Q 1.60
Inst Own 100.26%
Short Float 9.66%
Perf Quarter -13.71%
Sales 2.44B
P/S 1.94
EPS this Y 22.31%
Inst Trans -0.77%
Short Ratio 5.32
Perf Half Y -14.95%
Book/sh 33.70
P/B 1.23
EPS next Y 22.26%
ROA 12.82%
Short Interest 10.86M
Perf Year 9.43%
Cash/sh 4.26
P/C 9.74
EPS next 5Y 8.00%
ROE 22.71%
52W Range 34.13 - 53.26
Perf YTD 7.26%
Dividend Est. 0.74 (1.78%)
P/FCF 9.57
EPS past 5Y 8.90%
ROI 14.96%
52W High -22.02%
Beta 4.19
Dividend TTM 0.69 (1.66%)
Quick Ratio 1.29
Sales past 5Y 19.87%
Gross Margin 45.35%
52W Low 21.68%
ATR (14) 1.44
Dividend Ex-Date Jul 19, 2024
Current Ratio 1.29
EPS Y/Y TTM -21.53%
Oper. Margin 39.86%
RSI (14) 47.07
Volatility 2.92% 2.96%
Employees 544
Debt/Eq 0.41
Sales Y/Y TTM -7.11%
Profit Margin 33.18%
Recom 2.00
Target Price 56.00
Option/Short Yes / Yes
LT Debt/Eq 0.41
EPS Q/Q 45.59%
Payout 9.18%
Rel Volume 3.94
Prev Close 41.49
Sales Surprise 2.91%
EPS Surprise 21.53%
Sales Q/Q 15.22%
Earnings Aug 07 AMC
Avg Volume 2.04M
Price 41.53
SMA20 -1.86%
SMA50 -4.87%
SMA200 -5.49%
Trades
Volume 8,041,652
Change 0.10%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-21-24 Upgrade
Tudor, Pickering, Holt & Co.
Hold → Buy
Jun-25-24 Initiated
Truist
Hold
$51
Jun-21-24 Initiated
Stephens
Overweight
$63
Jan-31-24 Upgrade
Seaport Research Partners
Neutral → Buy
$50
Nov-15-23 Initiated
Wells Fargo
Equal Weight
$40
Aug-16-23 Upgrade
JP Morgan
Neutral → Overweight
$45 → $47
Mar-01-23 Downgrade
TD Cowen
Outperform → Market Perform
$35
Mar-01-23 Downgrade
Cowen
Outperform → Market Perform
$35
Jan-10-23 Initiated
Mizuho
Buy
$51
Jan-04-23 Downgrade
JP Morgan
Overweight → Neutral
$55 → $46
Sep-20-22 Initiated
KeyBanc Capital Markets
Overweight
$64
Jul-20-22 Resumed
MKM Partners
Buy
$54
Jan-05-22 Upgrade
Wells Fargo
Equal Weight → Overweight
$42
Dec-10-21 Upgrade
Cowen
Market Perform → Outperform
$34.25 → $42
Oct-26-21 Upgrade
Raymond James
Mkt Perform → Outperform
$45
Sep-15-21 Upgrade
JP Morgan
Neutral → Overweight
$27
Jun-10-21 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$18 → $27
Mar-09-21 Downgrade
Wells Fargo
Overweight → Equal Weight
$21
Feb-03-21 Upgrade
JP Morgan
Underweight → Neutral
$13
Jan-22-21 Upgrade
Siebert Williams Shank
Hold → Buy
Show Previous Ratings
Today 05:50PM
Sep-19-24 06:00PM
Sep-16-24 09:30AM
Sep-13-24 05:50PM
Sep-11-24 09:00AM
12:26PM
Loading…
Sep-09-24 12:26PM
08:00AM
Sep-06-24 11:31AM
Sep-05-24 06:00PM
Sep-04-24 11:13AM
Aug-28-24 07:01PM
09:55AM
09:00AM
Aug-23-24 09:40AM
Aug-15-24 09:30AM
09:40AM
Loading…
Aug-14-24 09:40AM
09:00AM
Aug-08-24 09:55AM
Aug-07-24 06:20PM
05:14PM
(Associated Press Finance)
04:15PM
09:40AM
Aug-05-24 08:24AM
Aug-01-24 09:00AM
05:43AM
(Thomson Reuters StreetEvents)
Jul-31-24 10:01AM
Jul-30-24 05:50PM
09:30AM
Jul-26-24 09:55AM
Jul-24-24 05:50PM
04:15PM
Loading…
04:15PM
09:40AM
Jul-22-24 06:00PM
09:40AM
Jul-19-24 09:00AM
Jul-18-24 05:12PM
09:21AM
08:00AM
02:07AM
Jul-16-24 06:00PM
Jul-13-24 06:18AM
Jul-10-24 08:58AM
Jul-08-24 06:00PM
12:52PM
12:51PM
12:26PM
12:00PM
Jul-01-24 09:00AM
08:48AM
Jun-28-24 09:26AM
Jun-27-24 07:14PM
(The Wall Street Journal) -10.47%
11:36AM
10:25AM
(The Wall Street Journal)
09:40AM
08:57AM
08:56AM
08:55AM
07:00AM
02:30AM
Jun-26-24 07:54PM
Jun-25-24 06:00PM
09:00AM
Jun-24-24 06:45AM
Jun-21-24 09:50AM
Jun-20-24 09:40AM
09:30AM
Jun-18-24 09:55AM
Jun-17-24 06:00PM
Jun-12-24 10:56AM
Jun-11-24 09:00AM
Jun-10-24 04:15PM
09:40AM
Jun-06-24 08:37AM
Jun-04-24 01:21PM
09:30AM
Jun-03-24 12:00PM
May-29-24 09:50AM
09:00AM
May-22-24 09:40AM
02:07AM
May-16-24 09:30AM
May-14-24 01:58PM
May-13-24 12:13PM
May-07-24 09:00AM
May-04-24 09:04AM
03:09AM
May-03-24 10:52PM
(Thomson Reuters StreetEvents) +5.01%
07:44AM
04:37AM
May-02-24 05:45PM
05:39PM
04:44PM
(Associated Press Finance)
04:15PM
May-01-24 02:08PM
Apr-30-24 09:30AM
Apr-29-24 12:00PM
Apr-26-24 09:00AM
Apr-25-24 09:00AM
Apr-24-24 09:50AM
Apr-23-24 05:45PM
SM Energy Co. is an independent energy company, which engages in the acquisition, exploration, development, and production of oil, gas, and natural gas liquids. The company was founded in 1908 and is headquartered in Denver, CO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Lytle Patrick A VP - Chief Accounting Officer Aug 26 '24 Sale 47.45 6,059 287,500 8,355 Aug 28 04:17 PM Lytle Patrick A Officer Aug 26 '24 Proposed Sale 47.45 6,059 287,481 Aug 26 05:04 PM Lebeck James Barker EVP & General Counsel Aug 16 '24 Sale 45.43 4,487 203,844 256 Aug 20 04:18 PM ROBESON ROSE M Director Aug 16 '24 Sale 45.50 10,000 455,000 33,381 Aug 20 04:17 PM Lebeck James Barker Officer Aug 16 '24 Proposed Sale 45.43 4,487 203,840 Aug 16 05:11 PM Rose M Robeson Revocable Trust Director Aug 16 '24 Proposed Sale 45.45 10,000 454,532 Aug 16 04:36 PM Knott Kenneth J. SVP - Bus Dev & Land May 21 '24 Sale 50.28 16,000 804,480 114,495 May 21 04:37 PM SULLIVAN WILLIAM D Director May 20 '24 Sale 49.32 60,000 2,959,200 89,157 May 21 04:34 PM Lutey Mary Ellen SVP - Expl., Development & EHS Mar 01 '24 Sale 44.50 43,506 1,936,017 12,472 Mar 05 04:26 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite